[HTML][HTML] Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome

ZA McIver, JJ Melenhorst, A Grim, N Naguib… - Biology of Blood and …, 2011 - Elsevier
ZA McIver, JJ Melenhorst, A Grim, N Naguib, G Weber, V Fellowes, H Khuu, DS Stroncek…
Biology of Blood and Marrow Transplantation, 2011Elsevier
We evaluated an ex vivo photodepletion (PD) technique to selectively deplete graft-versus-
host disease (GVHD) alloreacting T cells given to 24 human leukocyte antigen (HLA)-
identical sibling stem cell transplantation (SCT) recipients. Donor lymphocytes were
activated by 72-hour exposure to irradiated in vitro expanded recipient T lymphocytes and
pulsed with a TH9402 photosensitizer. Alloactivated T cells preferentially retaining the
photosensitizer were eliminated by light exposure. The PD product showed an inverted …
We evaluated an ex vivo photodepletion (PD) technique to selectively deplete graft-versus-host disease (GVHD) alloreacting T cells given to 24 human leukocyte antigen (HLA)-identical sibling stem cell transplantation (SCT) recipients. Donor lymphocytes were activated by 72-hour exposure to irradiated in vitro expanded recipient T lymphocytes and pulsed with a TH9402 photosensitizer. Alloactivated T cells preferentially retaining the photosensitizer were eliminated by light exposure. The PD product showed an inverted CD4+/CD8+ ratio with greatest depletion occurring in the CD4+ naive and central memory populations. In contrast, the CD8+ naive and effector cells were relatively conserved, reflecting the differential extrusion of TH9402 by T cell subsets. Cytomegalovirus reactive T cells were reduced in the PD product and in recipient blood 100 days after SCT when compared with contemporaneous HLA-identical sibling donor T cell-depleted SCT recipients. Although PD SCT recipients experienced similar absolute lymphocyte counts during the first 100 days after SCT, they achieved 100% donor T cell chimerism more rapidly and had higher CD8+ naive T cell counts early after SCT. SCT recipients of PD products with the lowest CD4 central memory content had the highest risk of developing chronic GVHD (cGVHD) (P = .04) and a poorer survival (P = .03). Although the persistence of CD8+ naive T cells may have contributed to important antileukemia responses resulting in a relatively low relapse rate, our findings emphasize the role of donor memory T cells and CD4 cells in establishing immune competence post-SCT. Although PD is associated with excellent outcomes in the haploidentical setting, the low frequency of alloactivations in HLA-matched pairs makes the PD approach used by our group for allodepletion in HLA-matched sibling transplantations an inefficient technique.
Elsevier